Current Context of Pneumonia Amidst the COVID-19 Pandemic in Africa

Uwishema, Olivier; Onyeaka, Helen; Alshareif, B.A. Abdalaziz; Omer, Mohammed Eltahier Abdalla; Sablay, Alfredo Lorenzo Recio; Tariq, Rabeet; Mohamed, Rayan Ibrahim Hamid; Zahabioun, Amirsaman; Yousif, Mohamed Yousif Elamin; Chalhoub, Elie; Tovani‐Palone, Marcos Roberto

doi:10.30935/jconseph/11281

Cited by 7 publications

(3 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, this was similar to the events that happened during the COVID-19 pandemic when countries in Africa received low numbers of vaccines at a delayed timeframe[ 14 ]. It is also possible that cases were underreported[ 15 ].…”

Section: Current Context Of Mpox Vaccinationsupporting

confidence: 57%

Inequity in the global distribution of monkeypox vaccines

Tovani‐Palone¹,

Doshi²,

Pedersini³

2023

World J Clin Cases

Self Cite

View full text Add to dashboard Cite

Monkeypox (mpox) has been a public health emergency of international concern that emerged in mid-2022 and has spread to 110 countries. The clinical findings of the disease vary according to the seriousness of the cases. Although its case fatality risk has not been high, a significant percentage of patients require hospitalization. In this context, local initiatives were taken to extend the limited supply of vaccines against the disease; however, such measures have not been sufficient to contain the spread of cases and ensure an equitable distribution of health resources. As a result, endemic regions of low-income countries continue to have insufficient access to mpox vaccination. Despite this and considering the global scope of the disease, there is still little discussion in the literature about the difficulties in achieving adequate vaccination coverage rates for the target population of interest. In this article, we briefly discussed general aspects of the disease, including its surveillance, the current global context of challenges for mpox vaccination, and issues on global allocation of health resources as well as proposed related recommendations.

show abstract

Section: Current Context Of Mpox Vaccinationsupporting

confidence: 57%

Inequity in the global distribution of monkeypox vaccines

Tovani‐Palone¹,

Doshi²,

Pedersini³

2023

World J Clin Cases

Self Cite

View full text Add to dashboard Cite

show abstract

“…However, this approach will require long‐term investments, large financial outlays, and adequate political will and commitment. Nevertheless, intersectional coordination of sanitary management, public healthcare awareness, and dietary initiatives by non‐medical groups and authorities can improve typhoid fever disease prevention and management 49,50 …”

Section: Recommendationsmentioning

confidence: 99%

“…Nevertheless, intersectional coordination of sanitary management, public healthcare awareness, and dietary initiatives by non-medical groups and authorities can improve typhoid fever disease prevention and management. 49,50 Clinicians could provide prompt treatment to produce a better prognosis after administering appropriate antimicrobial therapy, focussing upon optimal drug selection, dose, and treatment duration to ensure patient's recovery with minimal adverse effects. Thus, it is of paramount importance that clinicians are fully aware of the clinical presentation of the disease, and laboratory experts need to correct the way that the findings are present to avoid misdiagnosis.…”

Section: Recommendationsmentioning

confidence: 99%

Recent advances in the diagnosis and management of typhoid fever in Africa: A review

Mahmoud

Oluyemisi

Uwishema

et al. 2022

Health Planning & Management

Self Cite

View full text Add to dashboard Cite

Typhoid fever, a classical disease of enteric origin caused by Salmonella species of bacteria, is among the most important diseases threatening public health in Africa. The African continent is a marker for both low resources within the healthcare system and poor disease control policy formulations in managing endemic infectious diseases. Since the colonial era, the Widal serological test has been used to confirm typhoid fever in Africa, however recent studies recommend blood culture, and when blood culture cannot be obtained, clinical findings, laboratory Widal test confirmation, and ruling out other febrile illnesses as confirmatory pathway to diagnose typhoid fever in Africa.Managing typhoid fever relies on antimicrobials. In 1980s chloramphenicol was the medication of choice. Years later, amoxicillin and co-trimoxazole were adopted. However, the instantaneous rise of resistant strains of Salmonella enterica confers an important challenge to treat the burdensome enteric fever. The current treatment algorithm of typhoid fever in Africa relies significantly on the use of fluoroquinolones, macrolides, and cephalosporins. Developed nations have successfully addressed and controlled typhoid fever via improvement in accessing safe water and food, better sanitary and hygienic behaviours, and vaccines development. Nevertheless, there is significant evidence to

show abstract

Pneumonia amidst the COVID‐19 pandemic in Africa: Challenges and possible solutions

Uwishema

Onyeaka

Alshareif

et al. 2022

Health Science Reports

Self Cite

View full text Add to dashboard Cite

Africa has been significantly affected by the ongoing coronavirus disease 2019 (COVID-19) pandemic. It is noteworthy in this context that this is the continent with the poorest and most vulnerable populations to infectious diseases. 1 Since the emergence of the pandemic, scientific journals have published much literature on the topic; however, among the research articles published from June to December 2020, only 1.5% mentioned Africa in their titles or abstracts. Moreover, data from Sub-Saharan Africa underestimates the pandemic due to several factors, such as the overall low testing capacity and lack of laboratories, limited access to and weakness of health services, and political constraints, all of which suggest an imperative need for better reporting and further research on COVID-19 in Africa. 2 Pneumonia is the leading global cause of mortality in children under 5 years old. However, this disease still occurs frequently in working-age immunocompromised individuals and older adults (>70 y/o) with prior chronic conditions. [3][4][5] For decades, pneumonia has been the secondleading cause of admission to adult medical wards in Africa, behind only malaria. 6 Recently, although improved conjugate vaccines, such as the pneumococcal conjugate vaccine (PCV) and Haemophilus influenzae type b (HiB), have contributed to a decrease in the incidence and sever-

show abstract

Current Context of Pneumonia Amidst the COVID-19 Pandemic in Africa

Cited by 7 publications

References 15 publications

Inequity in the global distribution of monkeypox vaccines

Inequity in the global distribution of monkeypox vaccines

Recent advances in the diagnosis and management of typhoid fever in Africa: A review

Pneumonia amidst the COVID‐19 pandemic in Africa: Challenges and possible solutions

Contact Info

Product

Resources

About